Prescription Drug User Fee Act (PDUFA): 2017 Reauthorization as PDUFA VI
Description:
This report discusses the Prescription Drug User Fee Act (PDUFA) and its reauthorization as PDUFA VI. The bill allows the FDA to collect fees from pharmaceutical companies to support the review process for human drug applications. The various stages of drafting and passing the bill as well as changes from the most recent PDUFA are included.
Date:
June 8, 2017
Creator:
Dabrowska, Agata & Thaul, Susan
Item Type:
Refine your search to only
Report
Partner:
UNT Libraries Government Documents Department